Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nautilus Biotechnology Inc NAUT

Healthcare Advertising Agencies Biotechnology
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform... see more

Recent & Breaking News (NDAQ:NAUT)

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

GlobeNewswire August 4, 2023

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

GlobeNewswire August 2, 2023

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

GlobeNewswire July 11, 2023

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

GlobeNewswire May 24, 2023

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

GlobeNewswire May 2, 2023

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

GlobeNewswire April 18, 2023

Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies - Proteomics, Virtual Conference

GlobeNewswire March 23, 2023

Nautilus Biotechnology Announces "First Access Challenge" Winners

GlobeNewswire March 7, 2023

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

GlobeNewswire February 23, 2023

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

GlobeNewswire February 21, 2023

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

GlobeNewswire January 26, 2023

Nautilus Biotechnology Expands to San Diego

GlobeNewswire January 26, 2023

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

GlobeNewswire January 19, 2023

Nautilus Biotechnology Launches "First Access Challenge"

GlobeNewswire November 16, 2022

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

GlobeNewswire November 1, 2022

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

GlobeNewswire October 5, 2022

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

GlobeNewswire September 23, 2022

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

GlobeNewswire September 1, 2022

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire August 30, 2022

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

GlobeNewswire August 2, 2022